All In Biotech

Drug Trial Radar · NCT02004860

Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis

Phase 3 : Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis on Adult Face

Last checked: Nov 20, 2026Latest source record: May 29, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 120 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

120

Actual

Start

Jan 2014

Primary completion

Oct 2017

Study completion Oct 2017

Sponsor

Lead sponsor
University Hospital, RouenAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Dec 9, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Seborrheic dermatitis is a chronic inflammatory dermatological disease, evolving by relapses, affecting mainly the face and scalp. It would be important to have a maintenance treatment for severe forms of seborrheic dermatitis witch is both effective and relatively well tolerated to reduce the frequency of relapses, prolong remissions obtained after attack treatment and reduce the use of topical steroids.

Conditions

  • Severe Seborrheic Dermatitis

Interventions

  • Protopic (R)Drug

    Protopic® 0.1% ointment - 2 applications per week for 6 months

  • Mycoster (R)Drug

    Mycoster 1% - 2 applications per week for 6 months

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. duration of the maintenance of complete or almost complete clinical remissionTime frame: 18 months after inclusion (Visit (V) 4 last visit)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Rouen University Hospital

    Rouen, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.